Tubastatin A

Catalog No.S8049

For research use only.

Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis.

Tubastatin A Chemical Structure

CAS No. 1252003-15-8

Selleck's Tubastatin A has been cited by 76 publications

Purity & Quality Control

Choose Selective HDAC Inhibitors

Other HDAC Products

Biological Activity

Description Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis.
Targets
HDAC6 [1]
(Cell-free assay)
15 nM
In vitro

Tubastatin A is selective at all isozymes except HDAC8 and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. Tubastatin A preferentially induces α-tubulin hyperacetylation at 2.5 μM. Slight induction of histone hyperacetylation is seen for Tubastatin A at 10 μM. Tubastatin A displays dose-dependent protection against homocysteic acid-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM. [1] Tubastatin A (10 μM) induces an increase in acetylated-α-tubulin levels and the restoration of primary cilia expression in the cholangiocarcinoma cell lines (18-fold); and the restoration of primary cilia correlated with downregulated Hedgehog (Hh) and MAPK signaling pathways, as well as decreased cell proliferation rates (in average by 50%) and invasion (by 40%). [2] Tubastatin A shows significant inhibition of TNF-α and IL-6 in LPS stimulated human THP-1 macrophages with an IC50 of 272 nM and 712 nM. Tubastatin A inhibits nitric oxide (NO) secretion in murine Raw 264.7 macrophages dose depenndently with an IC50 of 4.2 μM. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Sf9 NHztZYNHfW6ldHnvckBie3OjeR?= NXfGWWpYOiCqcoO= NY\MdpV{UW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBPNXSncn3pcoFtKEeVVD30ZYdo\WRiSFTBR|YhMDFidH:gNVIyPSC{ZYPp[JVmeyliZYjwdoV{e2WmIHnuJJNnQSClZXzsd{BxemWrbnP1ZoF1\WRid3n0bEBmdnq7bXWg[o9tdG:5ZXSgZpkh\my3b4Lv[4VvcWNiQYLnMWhqey2OeYOtUJl{MEGlKT3BUWMhe3Wkc4TyZZRmKGGmZHn0bY9vKG2nYYP1doVlKGGodHXyJFIhcHK|IHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFAvODB|NTFOwG0v MkflQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd3NEGzOVcoRjJ5NUSxN|U4RC:jPh?=
Sf9 NXO3fm9{TnWwY4Tpc44h[XO|YYm= NFq4W3RKdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJIh2dWGwIILlZ49u[mmwYX70JG4ufGW{bXnuZYwhT1OWLYTh[4dm\CCKRFHDOkApOSC2bzCxNlE2KHKnc3nkeYV{MSCneIDy[ZN{\WRiaX6gd4Y6KGOnbHzzJJV{cW6pIGLIT{1MMEGlKT3BUWMh[XNic4Xid5Rz[XSnIHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFAvODFzIN88UU4> MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzV2MUO1O{c,Ojd3NEGzOVc9N2F-
Sf9 NY\uVZBFTnWwY4Tpc44h[XO|YYm= M2HUe|MxKG2rboO= M1fKNGlvcGmkaYTpc44hd2ZiZoXscEBt\W6pdHigbJVu[W5icnXjc41jcW6jboSgUk11\XKvaX7hcEBIW1RvdHHn[4VlKEiGQVO2JIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDz[lkh[2WubIOgeZNqdmdiZnz1c5Jw\2WwaXOgTGRCSyC|dXLzeJJifGViMzDh[pRmeiB|MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IECuNFE{KM7:TT6= Mli5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N|coRjJ7NUS5PFM4RC:jPh?=
Sf9 NWLVb5lHTnWwY4Tpc44h[XO|YYm= MVi5NEBucW6| Mn73TY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiC{ZXPvcYJqdmGwdDDOMZRmem2rbnHsJGdUXC22YXfn[YQhUESDQ{[g[ZhxemW|c3XkJIlvKFOoOTDj[YxteyC3c3nu[{BTUEuNKFHjLUBieyC|dXLzeJJifGViYX\0[ZIhQTBibXnud{BjgSCobIXvdolu\XS{aXOgcYV1cG:mLDDJR|UxKD1iMD6wNVM4KM7:TT6= MoDJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjhyM{izNlQoRjJ6MEO4N|I1RC:jPh?=
Sf9 MljISpVv[3Srb36gZZN{[Xl? NWrXb4MxOiCqcoO= NUHLWYF5UW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEPiCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJIlv[3WkYYTl[EBnd3JiMjDodpMhfXOrbnegVmhMUy2DYzDmcJVwem:pZX7pZ{B{fWK|dILheIUtKEmFNUCgQUAxNjBzNTFOwG0v NGTISo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{CwPVIxOyd-MkOwNFkzODN:L3G+
Sf9 NVLZfFJkTnWwY4Tpc44h[XO|YYm= NYDZdY85UW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEPiCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMwe2Z7IHPlcIx{KHW|aX7nJHJJU0uDYzDhd{B{fWK|dILheIUtKEmFNUCgQUAxNjBzNTFOwG0v MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzlyNU[4NEc,OjN7MEW2PFA9N2F-
Sf9 Mn7JSpVv[3Srb36gZZN{[Xl? M{\zS|kxKG2rboO= NGPmd5VKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IF6teIVzdWmwYXygS3NVNXSjZ3fl[EBnfWyuIHzlcod1cCCKRFHDOkBmgHC{ZYPz[YQhcW5iaX7z[YN1KFOIOTDj[YxteyC3c3nu[{BndHWxcn;n[Y5q[yCcTVHMJIF{KHO3YoP0doF1\SCjZoTldkA6OCCvaX7zJIJ6KG[udX;y[ZNk\W6lZT3iZZNm\CCjc4PhfUwhUUN3MDC9JFAvODNyNDFOwG0v MlPuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzByOUKzOlcoRjNyMEmyN|Y4RC:jPh?=
HeLaS3 NUWzZ2E{TnWwY4Tpc44h[XO|YYm= MlqxNVUhdWmwcx?= Mmr3TY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBJ\UyjU{OgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzNTDtbY5{KG[xbHzve4VlKGK7IFjERWMuT2yxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB|MDD0c{A1PSCvaX7zJIJ6KEWOSWPBMEBKSzVyIE2gNE4xOzFizszNMi=> NXXyNW93RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkizN|c{OTdpPkK4N|M4OzF5PD;hQi=>
insect cells NW\0eXh6TnWwY4Tpc44h[XO|YYm= MWi0JIhzew>? NGnIfVVKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWM3KGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EBqdnOnY4SgZ4VtdHNidYPpcochSkGWQ2CgZZMhe3Wkc4TyZZRmKGGodHXyJFQhcHK|IHL5JHVJWEyFLVXTTU1OWy:PUzDhcoFtgXOrczygTWM2OCB;IECuNFM1QSEQvF2u NWi2SJk5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
SHSY5Y Mn3nSpVv[3Srb36gZZN{[Xl? MknaPEBpenN? NWDXNpBxUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCVSGPZOXkh[2WubIOgeZNqdmdiQlHUR3Ah[XNic4Xid5Rz[XSnIHHmeIVzKDhiaILzJIJ6KFWKUFzDMWVUUS2PUz;NV{BidmGueYPpd{whUUN3MDC9JFAvODl2MzFOwG0v M{DKW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkWwPVI2Lz5{N{[1NFkzPTxxYU6=
SHSY5Y NXTBSXNMTnWwY4Tpc44h[XO|YYm= NXzJUG9ZQCCqcoO= M4LadmlvcGmkaYTpc44hd2ZiSFTBR{BqdiCqdX3hckBUUFO\NWmgZ4VtdHNidYPpcochVUGOIHHzJJN2[nO2cnH0[UBi\nSncjC4JIhzeyCkeTDVTHBNSy2HU1mtUXMwVVNiYX7hcJl{cXNuIFnDOVAhRSByLkGyNlEh|ryPLh?= NXTlSGV5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
Sf9 NH[yU3pHfW6ldHnvckBie3OjeR?= MWe0JIhzew>? MXvJcohq[mm2aX;uJI9nKG[3bHygcIVv\3SqIHj1cYFvKHKnY3;tZolv[W62IFOteIVzdWmwYXygSmxCTy:KaYOteIFo\2WmIFjERWMyKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EB{\jliY3XscJMhfXOrbneg[ox2d3KxZ3XubYMhUESDQzDzeYJ{fHKjdHWgN{Bi\nSncjC0JIhzeyCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkexPEDPxE1w M{HqUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUS5PFM4Lz5{OUW0PVg{PzxxYU6=
Sf9 NFPzVZJHfW6ldHnvckBie3OjeR?= NUWzSJVzUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEQCCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMwe2Z7IHPlcIx{KHW|aX7nJHJJU0GlS1HjJIF{KHO3YoP0doF1\SxiSVO1NEA:KDBwOEW0JO69VS5? NUjsOGY3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5NFU3QDBpPkKzPVA2PjhyPD;hQi=>
Sf9 MoW5SpVv[3Srb36gZZN{[Xl? NVPz[nVmOSCqch?= NV3OPW9PUW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBENXSncn3pcoFtKE[OQVevTIl{NXSjZ3fl[EBJTEGFMTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRic3[5JINmdGy|IIXzbY5oKG[udX;yc4dmdmmlIFjERWMhe3Wkc4TyZZRmKDNiYX\0[ZIhOSCqcjDmcJVwemW|Y3XuZ4Uh[XO|YYmsJGlEPTBiPTCwMlk3PyEQvF2u M4rmdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUS5PFM4Lz5{OUW0PVg{PzxxYU6=
SHSY5Y NFHh[lZHfW6ldHnvckBie3OjeR?= M3nZUlghcHK| NWPrRlliUW6qaXLpeIlwdiCxZjDISGFEOSCrbjDoeY1idiCVSGPZOXkh[2WubIOgeZNqdmdiTV;DVGFEKGG|IIP1ZpN1emG2ZTDh[pRmeiB6IHjyd{BjgSCXSGDMR{1GW0lvTWOvUXMh[W6jbInzbZMtKEmFNUCgQUAyNjFyOUeg{txONg>? MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzZ3MEmyOUc,Ojd4NUC5NlU9N2F-
Sf9 MoO1SpVv[3Srb36gZZN{[Xl? NG\USHY{OCCvaX7z NY\aWY1wUW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBENXSncn3pcoFtKE[OQVevTIl{NXSjZ3fl[EBJTEGFMTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRic3[5JINmdGy|IIXzbY5oKG[udX;yc4dmdmmlIFjERWMhe3Wkc4TyZZRmKDNiYX\0[ZIhOzBibXnud{BjgSCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVAhRSBzLkW0JO69VS5? MmrNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N|coRjJ7NUS5PFM4RC:jPh?=
Sf9 M{fvVmZ2dmO2aX;uJIF{e2G7 Mm\pPVAhdWmwcx?= Mk\WTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCFLYTldo1qdmGuIFjpd{9HVEGJLYTh[4dm\CCodXzsJIxmdme2aDDISGFEOSCneIDy[ZN{\WRiaX6gbY5{\WO2IGPGPUBk\WyuczD1d4lv\yCobIXvdo9o\W6rYzDaUWFNKGG|IIP1ZpN1emG2ZTDh[pRmeiB7MDDtbY5{KGK7IH\seY9z\XOlZX7j[U1j[XOnZDDhd5NigSxiSVO1NEA:KDFwOUGg{txONg>? MoTqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzByOUKzOlcoRjNyMEmyN|Y4RC:jPh?=
HCT116 NH\oS4RCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MnvOO|IhcHK| NGG1fmRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNkDPxE1w MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzV2MUO1O{c,Ojd3NEGzOVc9N2F-
HCT116 MYDBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M{nwe2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFPUNVE3KGOnbHzzMEBKSzVyIE2gNkDPxE1w MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2NUe5OUc,Ojl7NEW3PVU9N2F-
Sf9 NHXrZlVHfW6ldHnvckBie3OjeR?= M3z2eFMxKG2rboO= NHvQRW9KdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJIh2dWGwIILlZ49u[mmwYX70JGMufGW{bXnuZYwhUGm|LYTh[4dm\CCKRFHDN{9PNXSncn3pcoFtKEeVVD30ZYdo\WRiTlPPVlIhMDl3IITvJFQ5QSC{ZYPp[JVmeyliZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{KGmwZnXjeIVlKHOoOTDj[YxteyC3c3nu[{BndHWxcn;n[Y5q[yCKRFHDJJN2[nO2cnH0[UA{KGGodHXyJFMxKG2rboOgZpkh\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOi5{NjFOwG0v MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV2OUizO{c,Ojl3NEm4N|c9N2F-
HeLa NFz2RWtHfW6ldHnvckBie3OjeR?= MoTaOkBpenN? NWflc4RmUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCKZVzhJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCNNECgbJlx\XKjY3X0fYxifGmxbjDv[kBidHCqYT30eYJ2dGmwIHnuZ5Vj[XSnZDDmc5IhPiCqcoOgZpkhcW2vdX7v[ox2d3Knc3PlcoNmKGG|c3H5MEBKSzVyIE2gNk42KM7:TT6= NHuzWXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS1OFI4OCd-MkW0OVQzPzB:L3G+
HL60 M3vwWWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MoT0OFghcHK| MXXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiONkCgZ4VtdHNiYX\0[ZIhPDhiaILzJIlvKHC{ZYPlcoNmKG:oIFrBT|IhcW6qaXLpeI9zKEO\VD2zPFch[nliQ1PLMVgh[XO|YYmsJGlEPTBiPTCyMlU1KM7:TT6= NWKy[W1PRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFAyOTVpPkK5PVQxOTF3PD;hQi=>
K562 MXLBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MX:0PEBpenN? M2PheWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iS{W2NkBk\WyuczDh[pRmeiB2ODDodpMhcW5icILld4Vv[2Vib3[gTmFMOiCrbnjpZol1d3JiQ2nUMVM5PyCkeTDDR2suQCCjc4PhfUwhUUN3MDC9JFIvPTRizszNMi=> NHXtUpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFEyPSd-Mkm5OFAyOTV:L3G+
HEL NHrEO2lCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MoDwOFghcHK| M2DsOGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFXMJINmdGy|IHHmeIVzKDR6IHjyd{BqdiCycnXz[Y5k\SCxZjDKRWszKGmwaHnibZRweiCFWWStN|g4KGK7IFPDT{05KGG|c3H5MEBKSzVyIE2gNk42PCEQvF2u NXLrbYV{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFAyOTVpPkK5PVQxOTF3PD;hQi=>
HeLaS3 MUPGeY5kfGmxbjDhd5NigQ>? MkXoNVUhdWmwcx?= MlfFTY5pcWKrdHnvckBw\iCKRFHDNUBqdiCqdX3hckBJ\UyjU{OgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzNTDtbY5{KG[xbHzve4VlKGK7IFjERWMuT2yxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB|MDD0c{A1PSCvaX7zJIJ6KEWOSWPBMEBKSzVyIE2gNk44KM7:TT6= M4q0SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6M{O3N|E4Lz5{OEOzO|MyPzxxYU6=
HeLaS3 NVzBTHVrTnWwY4Tpc44h[XO|YYm= M1:wPFE2KG2rboO= M3fjSGlvcGmkaYTpc44hd2ZiSFTBR|MhcW5iaIXtZY4hUGWOYWOzJINmdGy|IIDy[Ylv[3WkYYTl[EBnd3JiMUWgcYlveyCob3zsc5dm\CCkeTDISGFENUeubzDzeYJ{fHKjdHWgZYRlcXSrb36gcYVie3W{ZXSgZYZ1\XJiM{CgeI8hPDVibXnud{BjgSCHTFnTRUwhUUN3MDC9JFIvQSEQvF2u NIDFZ4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEOzO|MyPyd-MkizN|c{OTd:L3G+
Jurkat NHX3OXREgXSxdH;4bYNqfHliYYPzZZk> NInGfpQ4OiCqcoO= MmrOR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTpVzc2G2IHPlcIx{KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDd{IHjyd{BjgSCPVGOgZZN{[XluIFnDOVAhRSB|LkO4JO69VS5? MnexQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR|MESzOFgoRjJ2M{C0N|Q5RC:jPh?=
MCF7 NWXxXFJQSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MmXHO|IhcHK| MWXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDNwNzFOwG0v NHnISI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W0NVM2Pyd-Mke1OFE{PTd:L3G+
MCF7 NFW3RmdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MW\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNuIFnDOVAhRSB|Lkeg{txONg>? MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2NUe5OUc,Ojl7NEW3PVU9N2F-
HL60 MY\BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NYLSW|B5PDhiaILz MoeyRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKTE[wJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCFQ1utPEBie3OjeTygTWM2OCB;IEOuO|Uh|ryPLh?= NG[weYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFEyPSd-Mkm5OFAyOTV:L3G+
K562 NVftVlNUSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NWHQ[Yd[PDhiaILz NWHMXGFRSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDLOVYzKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDDR2suQCCjc4PhfUwhUUN3MDC9JFMvPzVizszNMi=> MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MEGxOUc,Ojl7NECxNVU9N2F-
HEL MWXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MlPwOFghcHK| M2KwbWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFXMJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCFQ1utPEBie3OjeTygTWM2OCB;IEOuO|Uh|ryPLh?= NGnDUJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFEyPSd-Mkm5OFAyOTV:L3G+
HeLaS3 M2fUXmZ2dmO2aX;uJIF{e2G7 NVzRTXZ4OTVibXnudy=> MWTJcohq[mm2aX;uJI9nKEiGQVOyJIlvKGi3bXHuJGhmVGGVMzDj[YxteyCycnXpcoN2[mG2ZXSg[o9zKDF3IH3pcpMh\m:ubH;3[YQh[nliSFTBR{1IdG9ic4Xid5Rz[XSnIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDNyIITvJFQ2KG2rboOgZpkhTUyLU1GsJGlEPTBiPTCzMlkh|ryPLh?= NGrYT2o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEOzO|MyPyd-MkizN|c{OTd:L3G+
CAL27 MmHDRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MWO3NkBpenN? Mk[5RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFQVyyO{Bk\WyuczDt[YF{fXKnZDDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iND62JO69VS5? MkTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3OEGyPFkoRjJ6NUixNlg6RC:jPh?=
PC3 MoLKRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M1TEOVczKGi{cx?= M2jLWWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB6Lk[g{txONg>? NEHlOIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W0NVM2Pyd-Mke1OFE{PTd:L3G+
PC3 NGe1W|FCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M4jtfmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|LDDJR|UxKD1iOD62JO69VS5? MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2NUe5OUc,Ojl7NEW3PVU9N2F-
Sf9 MUPGeY5kfGmxbjDhd5NigQ>? NGTMbHQ{OCCvaX7z NGPmeppKdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJIh2dWGwIILlZ49u[mmwYX70JGMufGW{bXnuZYwhUGm|LYTh[4dm\CCKRFHDNkBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOgbY5n\WO2ZXSgd4Y6KGOnbHzzJJV{cW6pIH\seY9zd2enbnnjJGhFSUNic4Xid5Rz[XSnIEOgZYZ1\XJiM{CgcYlveyCkeTDmcJVwemW|Y3XuZ4Uh[XO|YYmsJGlEPTBiPTC5Mlk4KM7:TT6= MoW5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N|coRjJ7NUS5PFM4RC:jPh?=
MDA-MB-231 NYrrT2NiSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MY[3NkBpenN? MXnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFExNjRizszNMi=> Mn;CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd3NEGzOVcoRjJ5NUSxN|U4RC:jPh?=
MDA-MB-231 M4\zXmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MmW5RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPRFGtUWIuOjNzIHPlcIx{NCCLQ{WwJF0hOTBwNDFOwG0v NFryUZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0OVc6PSd-Mkm5OFU4QTV:L3G+
Cal27CisR MkfJRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M4DtWFczKGi{cx?= MV7BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEOjbEK3R4l{WiClZXzsd{Bu\WG|dYLl[EBi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNVAvQCEQvF2u NF\ZWlU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEW4NVI5QSd-Mki1PFEzQDl:L3G+
LNCAP MoLkR5l1d3SxeHnjbZR6KGG|c3H5 NFvUbXY4OiCqcoO= MYDDfZRwfG:6aXPpeJkh[WejaX7zeEBidmS{b3flck1l\XCnbnTlcpQhcHWvYX6gUG5ESVBiY3XscJMh[XO|ZYPz[YQh[XNiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhPzJiaILzJIJ6KE2WUzDhd5NigSxiSVO1NEA:KDFyLki4JO69VS5? NHW3Ros9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEOwOFM1QCd-MkSzNFQ{PDh:L3G+
Cal27CisR NVnvSHdYTnWwY4Tpc44h[XO|YYm= NWrnTIc6OThiaILz MkX6TY5pcWKrdHnvckBw\iCKRFHDJIlvKGi3bXHuJGNidDJ5Q3nzVkBk\WyuczD1d4lv\yCEb3OtUJl{MGWyc3nsc44uSWNrLVHNR{BieyC|dXLzeJJifGVicILlbY5kfWKjdHXkJIZweiBzODDodpMh\m:ubH;3[YQh[nlic4Xid5Rz[XSnIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDNiaILzJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiSVO1NEA:KDF{LkGg{txONg>? NEDsSIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEW4NVI5QSd-Mki1PFEzQDl:L3G+
KB MkS1R5l1d3SxeHnjbZR6KGG|c3H5 NHWxPWM4OiCqcoO= M4\Q[mN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGtDKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHMh[XO|YYmsJGlEPTBiPTCxOE45OSEQvF2u M4C1ZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEm5N|M5Lz5{NUi5PVM{QDxxYU6=
THLE2 NIfzW5hEgXSxdH;4bYNqfHliYYPzZZk> NWW4bWRbPzJiaILz M1:3bmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHRJVEV{IHPlcIx{KGGodHXyJFczKGi{czDifUB3cWGuaXfoeEBk\WyuIIDyc4xq\mW{YYTpc44h[XO|YYmsJGxEPTBiPTCxOU4yKM7:TT6= NFXnNIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW0PVg{Pyd-Mkm1OFk5Ozd:L3G+
CAL27 M2DBUWZ2dmO2aX;uJIF{e2G7 MmL3NVghcHK| MmDtTY5pcWKrdHnvckBw\iCKRFHDJIlvKGi3bXHuJGNCVDJ5IHPlcIx{KHW|aX7nJGJw[y2OeYOo[ZB{cWyxbj3BZ{kuSU2FIHHzJJN2[nO2cnH0[UBxemWrbnP1ZoF1\WRiZn;yJFE5KGi{czDmc4xtd3enZDDifUB{fWK|dILheIUh[WSmaYTpc44hdWWjc4Xy[YQh[W[2ZYKgN{BpenNiYomg[ox2d3Knc3PlcoNmKGG|c3H5MEBKSzVyIE2gNVYvOSEQvF2u NYHKV3p6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki1PFEzQDlpPkK4OVgyOjh7PD;hQi=>
Sf9 M1qzSGZ2dmO2aX;uJIF{e2G7 M2jUR|IhcHK| NXXCNoI{UW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOSCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJIlv[3WkYYTl[EBnd3JiMjDodpMhfXOrbnegVmhMUy2DYzDmcJVwem:pZX7pZ{B{fWK|dILheIUtKEmFNUCgQUAyPi52IN88UU4> NXTOcpN5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNFkzODNpPkKzNFA6OjB|PD;hQi=>
Sf9 MUjGeY5kfGmxbjDhd5NigQ>? M2XDUGlvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiSFTBR|Eh\XiycnXzd4VlKGmwIHLhZ5Vtd3[rcoXzM5NnQSClZXzsd{B2e2mwZzDSTGtMSWNiYYOgd5Vje3S{YYTlMEBKSzVyIE2gNVYvPCEQvF2u MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzlyNU[4NEc,OjN7MEW2PFA9N2F-
B16 NFrVfpFIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M{PEcVQ5KGi{cx?= NYP4WWg1T3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhSjF4IHPlcIx{KGmwY4XiZZRm\CCob4KgOFghcHK|IHL5JG1VXCCjc4PhfUwhT0l3MDC9JFQxNjVizszNMi=> NYnwXoJYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwNFkzODNpPkKzNFA6OjB|PD;hQi=>
KB M2TzWmZ2dmO2aX;uJIF{e2G7 MYexOEB2VQ>? M{TvdVI1KGi{cx?= NWTX[5RvUW6qaXLpeIlwdiCxZjDISGFEOSCrbjDoeY1idiCNQjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBpcXO2b37lJGg1KGGlZYT5cIF1cW:wIHH0JFE1KHWPIHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5oKGGwYXz5d4l{ NFv4UYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUi5PVM{QCd-MkW4PVk{Ozh:L3G+
KMS-12-BM NUHDRVlyTnWwY4Tpc44h[XO|YYm= MnnsNVUhfU1? NFfiXHp2eCC2bzC0PEBpenN? NU\XSmFzUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCNTWOtNVIuSk1iY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNmfHmuYYTl[EB1fWK3bHnuJIxmfmWuIHH0JFE2KHWPIIXwJJRwKDR6IHjyd{BjgSCrbX31co9jdG:2IH3leIhw\A>? M2q3T|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NUSxN|U4Lz5{N{W0NVM2PzxxYU6=
MOLM14 MlfFSpVv[3Srb36gZZN{[Xl? NGf4XGUyPSC3TR?= M1zaXJVxKHSxIES4JIhzew>? NX7xdnNGUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCPT1zNNVQh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iYXPleJlt[XSnZDD0eYJ2dGmwIHzleoVtKGG2IEG1JJVOKHWyIITvJFQ5KGi{czDifUBqdW23bn;icI91KG2ndHjv[C=> MkjKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd3NEGzOVcoRjJ5NUSxN|U4RC:jPh?=
U937 NWrhfnBJTnWwY4Tpc44h[XO|YYm= M{LHflIhfU1? M3XRcVE5KGi{cx?= MXzJcohq[mm2aX;uJI9nKEiGQVO2JIlvKGi3bXHuJHU6OzdiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYxxcGFvdIXieYxqdiCjY3X0fYxifGmxbjDheEBNgXNvNECgdoV{cWS3ZTDheEAzKHWPIHHmeIVzKDF6IHjyd{BjgSCZZYP0[ZJvKGKub4SgcYV1cG:m NGPKNW09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEOzO|MyPyd-MkizN|c{OTd:L3G+
LNCAP NGLROpZHfW6ldHnvckBie3OjeR?= MYCyOEBpenN? MnrVTY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBNVkODUDDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKESKVD3pcoR2[2WmIHHsdIhiNXS3YoXsbY4h\GWjY3X0fYxifGmxbjDifUBu\WG|dYLpcochcW6lcnXhd4UhcW5iYXzwbIEufHWkdXzpckBi[2W2eXzheIlwdiCvZXHzeZJm\CCjZoTldkAzPCCqcoOgdoVt[XSrdnWgeI8h[2:wdILvcC=> M1zjVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5N{G3OVQ1Lz5{N{exO|U1PDxxYU6=
human NEn5S3BHfW6ldHnvckBie3OjeR?= MoHpNlQhcHK| NFG1S2pCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IFHSJIlvKGi3bXHuJGxPS0GSIHPlcIx{KGG|c3Xzd4VlKGG|IIP1dJBz\XO|aX;uJI9nKESKVD3pcoR2[2WmIFHSJJBzd3SnaX6gcIV3\WxibXXhd5Vz\WRiYX\0[ZIhOjRiaILzJJJmdGG2aY\lJJRwKGOxboTyc4w> Mo\DQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd5MUe1OFQoRjJ5N{G3OVQ1RC:jPh?=
DAOY M2nqW5FJXFNiYYPzZZk> M1HVU5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCGQV;ZJINmdGy| NVvUe|Z2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SJ-GBM2 NITmXlByUFSVIHHzd4F6 MmnqdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOMLVfCUVIh[2WubIO= MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
A673 Mm\UdWhVWyCjc4PhfS=> Mor3dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? Mlz1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC NVXhbpNWeUiWUzDhd5NigQ>? MUjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 M3XOdZFJXFNiYYPzZZk> MoT1dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUO3JINmdGy| MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB-EBc1 M4jw[JFJXFNiYYPzZZk> NXvHdIh5eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CMWVD[zFiY3XscJM> NUDXeHVDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
U-2 OS NVixPI5keUiWUzDhd5NigQ>? M{WxSZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCXLUKgU3Mh[2WubIO= MmrBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Saos-2 Mn\CdWhVWyCjc4PhfS=> M3KyTJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVYX;zMVIh[2WubIO= NF\jVmg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH M4[wbpFJXFNiYYPzZZk> MXvxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3TTEBk\Wyucx?= NXnlS4ZuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB1643 MV;xTHRUKGG|c3H5 M1OzWJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQkG2OFMh[2WubIO= NVPlT2RiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
LAN-5 Mo\idWhVWyCjc4PhfS=> NUD2RpVseUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFzBUk02KGOnbHzz NXPlUFBDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 NEXtVmJyUFSVIHHzd4F6 MWTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>? MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
OHS-50 Ml\DdWhVWyCjc4PhfS=> NVrvVJdUeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF;IV{02OCClZXzsdy=> NWG3Z4dzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD M3T5e5FJXFNiYYPzZZk> M4PQRZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCURDDj[Yxtew>? NX3lPJpwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh30 MX;xTHRUKGG|c3H5 NWjkW2w2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoN|Ah[2WubIO= NYLkTG1bRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh41 M2\0Z5FJXFNiYYPzZZk> M2T6UJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaESxJINmdGy| NWCyNJN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
HEL M3nmUmNmdGxiY4njcIUh[XO|YYm= MmO0NUB1dyB3IIXN M1mzRVQ5KGi{cx?= Mn;IR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gTGVNKGOnbHzzJIF{e2W|c3XkJIF{KGGlY4XteYxifGmxbjDheEBIOSCyaHHz[UBifCBzIITvJFUhfU1iYX\0[ZIhPDhiaILzJJBzd3CrZHn1cUBqd2SrZHWgd5RicW6rbnegZoF{\WRiZnzve{BkgXSxbXX0dpk> NXG3XYJORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFAyOTVpPkK5PVQxOTF3PD;hQi=>
HeLa M1fBT2Z2dmO2aX;uJIF{e2G7 M1zyflIhfU1? NXfK[Y9vOTJiaILz NYjUcJV2UW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCKZVzhJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGGlZYT5cE11fWK3bHnuJIxmfmWuIHH0JFIhfU1iYX\0[ZIhOTJiaILzJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrcx?= NFS1S249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUWzN|g4Oyd-Mkm1N|M5PzN:L3G+
HEK293 NICwcItHfW6ldHnvckBie3OjeR?= MUWxNEB2VQ>? MWqyOEBpenN? NYfPdFBJUW6qaXLpeIlwdiCxZjDISGFEOSCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{Bi[2W2eXzheIlwdiCjdDCxNEB2VSCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IH3leIhw\A>? NEPYXoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEWyN|ExOid-Mki1NlMyODJ:L3G+
MV4-11 NWLxS21TTnWwY4Tpc44h[XO|YYm= M1TmTFIxOCCwTR?= MV6yOEBpenN? M3TEXGlvcGmkaYTpc44hd2ZiSFTBR|YhcW5iaIXtZY4hVVZ2LUGxJINmdGy|IHHzd4V{e2WmIHHzJIFk[3WvdXzheIlwdiCxZjDhZ4V1gWyjdHXkJIFteGijLYT1ZpVtcW5iYYSgNlAxKG6PIHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm|aYO= MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTd|OEm1N{c,Ojl5M{i5OVM9N2F-
HCT116 NFfK[3JE\WyuIHP5Z4xmKGG|c3H5 M2nl[|UhfU1? NXPFOWVXPDhiaILz MXnD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KHO3Yj3HNUBxcGG|ZTDheEA2KHWPIHHmeIVzKDR6IHjyd{BjgSCycn;wbYRqfW1iaX;kbYRmKHO2YXnubY5oNWKjc3XkJIZtd3diY4n0c41mfHKrYzDt[ZRpd2R? MoXFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjhyM{izNlQoRjJ6MEO4N|I1RC:jPh?=
PC12 MmroUoV2em:ycn;0[YN1cX[nIHHzd4F6 NH3YbpQyOCC3TR?= NEX3OZIzPCCqcoO= MVPO[ZVzd3C{b4TlZ5RqfmViYXP0bZZqfHliYXfhbY5{fCCKMl:yMYlv\HWlZXSgeI95cWOrdImgbY4hemG2IGDDNVIh[2WubIOgZZN{\XO|ZXSgZZMh[2WubDD2bYFjcWyrdImgZZQhOTBidV2gdJJmfHKnYYTl[EBnd3JiMkSgbJJ{KG[xbHzve4VlKGK7IFiyU|Ih[2ijbHzlcodmKGGwZDDt[YF{fXKnZDDh[pRmeiBzMjDodpMh[nliTWTUJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3y= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 NGHCfHZP\XW{b4Dyc5Rm[3SrdnWgZZN{[Xl? MVe1JJVO MVyyOEBpenN? M4PadG5mfXKxcILveIVkfGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IE[tU2hFSS2rbnT1Z4VlKHSxeHnjbZR6KGmwIILheEBRSzF{IHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJINmdGxidnnhZoltcXS7IHH0JFUhfU1icILleJJm[XSnZDDmc5IhOjRiaILzJIZwdGyxd3XkJIJ6KDZvT1jERUBkcGGubHXu[4Uh[W6mIH3lZZN2emWmIHHmeIVzKDF{IHjyd{BjgSCPVGSgZZN{[Xl? MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 NFnUbYtP\XW{b4Dyc5Rm[3SrdnWgZZN{[Xl? NU\4RmVQOTBidV2= MmCyNlQhcHK| NFrtcm5P\XW{b4Dyc5Rm[3SrdnWgZYN1cX[rdImgZYdicW6|dDC2MW9JTEFvaX7keYNm\CC2b4jpZ4l1gSCrbjDyZZQhWENzMjDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBk\WyuII\pZYJqdGm2eTDheEAyOCC3TTDwdoV1emWjdHXkJIZweiB{NDDodpMh\m:ubH;3[YQh[nliNj3PTGRCKGOqYXzs[Y5o\SCjbnSgcYVie3W{ZXSgZYZ1\XJiMUKgbJJ{KGK7IF3UWEBie3OjeR?= MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 M4TNUmN6fG:ycn;0[YN1cX[nIHHzd4F6 MlfWNlQhcHK| MXXDfZRweHKxdHXjeIl3\SCjY4Tpeol1gSCjZ3HpcpN1KEh{T{KtbY5lfWOnZDDkZY1i\2ViaX6gdoF1KFCFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWk:VIHHjZ5VufWyjdHnvckBxemWrbnP1ZoF1\WRiZn;yJFI1KGi{czDmc4xtd3enZDDifUBJOk9{IHPoZYxt\W6pZTDt[YF{fXKnZDDh[pRmeiBzMjDodpMh[nliRFPGTE1FSSCmeXWtZoF{\WRiZnz1c5Jme2OnbnPlJIFv[Wy7c3nz MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 NFH6cnlEgXSxcILveIVkfGm4ZTDhd5NigQ>? NV:yWVJROjRiaILz MWrDfZRweHKxdHXjeIl3\SCjY4Tpeol1gSCjZ3HpcpN1KEh{T{KtbY5lfWOnZDDkZY1i\2ViaX6gdoF1KFCFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWk:VIHHjZ5VufWyjdHnvckBxemWrbnP1ZoF1\WRiZn;yJFI1KGi{czDmc4xtd3enZDDifUBJOk9{IHPoZYxt\W6pZTDt[YF{fXKnZDDh[pRmeiBzMjDodpMh[nliRFPGTE1FSSCmeXWtZoF{\WRiaX72[ZJ1\WRiZnz1c5Jme2OnbnPlJI1q[3Kxc3PvdIlkKGGwYXz5d4l{ MljnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB|OEWyNlcoRjNyM{i1NlI4RC:jPh?=
PC12 MlTlUoV2em:ycn;0[YN1cX[nIHHzd4F6 NYTWTFgxPSC2bzCxNEB2VQ>? MkLJNlQhcHK| M1jqcW5mfXKxcILveIVkfGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IE[tU2hFSS2rbnT1Z4VlKHSxeHnjbZR6KGmwIILheEBRSzF{IHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJINmdGxidnnhZoltcXS7IHH0JFUhfG9iMUCgeW0heHKndILlZZRm\CCob4KgNlQhcHK|IH\vcIxwf2WmIHL5JFYuV0iGQTDjbIFtdGWwZ3WgZY5lKG2nYYP1doVlKGGodHXyJFEzKGi{czDjc4lv[3WkYYTl[EB4cXSqIHXid4Vt\W5iYomgUXRVKGG|c3H5 MkiwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB|OEWyNlcoRjNyM{i1NlI4RC:jPh?=
PC12 NFixeWlCdnSrb4jp[IFvfCCjc4PhfS=> NXXoRXpLPSC3TR?= M2LuSFI1KGi{cx?= MoPZRY51cW:6aXThcpQh[WO2aY\peJkh[WejaX7zeEBJOk9{LXnu[JVk\WRib4jp[IF1cX[nIIP0doV{eyCrbjDyZZQhWENzMjDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBTV1NiYXPjeY12dGG2aX;uJIF1KDVidV2gdJJmcW6ldXLheIVlKG[xcjCyOEBpenNiZn;scI94\WRiYomgTFJQOiClaHHscIVv\2ViYX7kJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyCkeTDER2ZJNUSDIHT5[U1j[XOnZDDmcJVwemW|Y3XuZ4Uh[W6jbInzbZM> MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 NIfKbldCdnSrb4jp[IFvfCCjc4PhfS=> NYHwUHpkPSC3TR?= NV3HNoQ{OjRiaILz M1i3SGFvfGmxeHnkZY51KGGldHn2bZR6KGGpYXnud5QhUDKRMj3pcoR2[2WmIH;4bYRifGm4ZTDzeJJme3NiaX6gdoF1KFCFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWk:VIHHjZ5VufWyjdHnvckBifCB3IIXNJJBz\WmwY4XiZZRm\CCob4KgNlQhcHK|IH\vcIxwf2WmIHL5JGgzVzJiY3jhcIxmdmenIHHu[EBu\WG|dYLl[EBi\nSncjCxNkBpenNiY3;pcoN2[mG2ZXSge4l1cCCnYoPlcIVvKGK7IFTDSmguTEFiZInlMYJie2WmIH\seY9z\Q>? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
Assay
Methods Test Index PMID
Western blot EGFR / p-AKT / AKT / p-ERK / ERK 29665050
Immunofluorescence α-tubulin / Acetylated tubulin ; HDAC6 23798680
In vivo Tubastatin A reduces the growth of cholangiocarcinoma in vivo. Tubastatin A (10 mg/kg) induces a 6-fold lower mean tumor weights in syngeneic rat orthotopic model of cholangiocarcinoma, and reduction of the ratios of tumor weight to liver weight and body weight (5- and 5.6-fold, respectively), as well as a greater frequency of ciliated cholangiocytes compared with controls (29% vs 1.4%). Tubastatin A significantly decreases the amount of PCNA-positive cells in the treated tumors compared with vehicle controls (34% vs 65%). [2] Tubastat A shows significant inhibition of paw volume at 30 mg/kg i.p. in a Freund's complete adjuvant (FCA) induced animal model of inflammation. Tubastat A (30 mg/kg i.p.) significant attenuates clinical scores (~ 70%), and IL-6 expression in paw tissues of collagen induced arthritis DBA1 mouse. [3]

Protocol (from reference)

Kinase Assay:

[4]

  • HDAC enzymatic assays:

    Tubastatin A is dissolved and diluted in assay buffer (50 mM HEPES, pH 7.4, 100 mM KCl, 0.001% Tween-20, 0.05% BSA, and 20 μM tris(2-carboxyethyl)phosphine) to 6-fold of the final concentration. HDAC enzymes are diluted to 1.5-fold of the final concentration in assay buffer and pre-incubated with Tubastatin A for 10 minutes before the addition of the substrate. The amount of FTS (HDAC1, HDAC2, HDAC3, and HDAC6) or MAZ-1675 (HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9) used for each enzyme is equal to the Michaelis constant (Km), as determined by a titration curve. FTS or MAZ-1675 is diluted in assay buffer to 6-fold the final concentration with 0.3 μM sequencing grade trypsin. The substrate/trypsin mix is added to the enzyme/compound mix and the plate is shaken for 60 seconds and then placed into a SpectraMax M5 microtiter plate reader. The enzymatic reaction is monitored for release of 7-amino-4-methoxy-coumarin over 30 minutes, after deacetylation of the lysine side chain in the peptide substrate, and the linear rate of the reaction is calculated.

Cell Research:

[2]

  • Cell lines: Human cholangiocarcinoma cell lines HuCCT-1
  • Concentrations: ~10 μM
  • Incubation Time: 21 days
  • Method:

    Anchorage-independent growth is assessed by growing cells in soft agar. About 25,000 cells suspended in 0.4% agar in culture media are layered over a 1% agar layer in a 6-well plate. Media are added twice a week and pictures are taken after 21 days of incubation. The number and size of colonies are analyzed using the Gel-Pro software.

  • (Only for Reference)
Animal Research:

[2]

  • Animal Models: Rat cholangiocarcinoma xenografts BDEneu
  • Dosages: 10 mg/kg
  • Administration: i.p. daily
  • (Only for Reference)

Solubility (25°C)

In vitro

DMSO 67 mg/mL warmed
(199.76 mM)
Water Insoluble
Ethanol Insoluble

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
5% DMSO+40% PEG 300+5%Tween 80+50% ddH2O
For best results, use promptly after mixing.

1.67mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 335.4
Formula

C20H21N3O2

CAS No. 1252003-15-8
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
We are planning to order some tubastatin A but I found out there are two versions of it. One has HCl and one does not. Which one do you recommend for live cell use? Will the HCl containing version significantly change the pH?

Answer:
S8049 and S2627 have same molecular structure. The only difference is S2627 containing HCl and has higher solubility in DMSO (74 mg/mL vs. S8049 9 mg/mL). Since they are the same molecule, the biological function should be similar. I would recommend to use S2627 for cell culture study.

Question 2:
What’s the vehicle do you recommend to dissolve the compound for in vivo experiments?

Answer:
S8049 Tubastatin A can be dissolved in 2% DMSO/30% PEG 300/PBS at 2.5 mg/mL as a clear solution, and it is also a clear solution in 2% DMSO/ corn oil at 2.5 mg/mL. The drug in 2% DMSO/0.5% Tween 80/PBS is a homogeneous suspension at 2.5 mg/mL at first. After stay for a while, the precipitation goes out at the bottom of the tube.

Tags: buy Tubastatin A | Tubastatin A supplier | purchase Tubastatin A | Tubastatin A cost | Tubastatin A manufacturer | order Tubastatin A | Tubastatin A distributor